Physician profile
Ryan Hudson Fitzgerald
NPI 1760649602
$43,060.83
in general payments reported to CMS, 2019-2025
36 companies · $5,854 in 2025
The $5,854 reported for 2025 was more than what 97% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $2,693 · 2021: $6,561 · 2022: $14K · 2023: $262 · 2024: $1,926 · 2025: $5,854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,600 · Travel and Lodging: $2,622 · Food and Beverage: $1,820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,600.00 |
| Travel and Lodging | $2,622.42 |
| Food and Beverage | $1,819.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novastep INC. | $17,530.29 | 2021-2022 | |
| Organogenesis INC. | $8,501.50 | 2019-2020 | |
| Stryker Corporation | $6,617.97 | 2020-2025 | Prostep, Prostep Mica, Infinity |
| Kerecis Limited | $5,817.37 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Wright Medical Technology, INC. | $1,975.98 | 2019-2020 | |
| Kuros Biosciences USA, INC | $1,000.00 | 2025 | Magnetos |
| Smith+Nephew, INC. | $345.67 | 2019-2025 | Stravix, Q-Fix, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Zyla Life Sciences, INC. | $305.26 | 2019-2020 | |
| Polarityte, INC. | $163.61 | 2019 | |
| Horizon Therapeutics Plc | $93.38 | 2019-2021 | |
| Crossroads Extremity Systems, LLC | $82.19 | 2019 | |
| Zimmer Biomet Holdings, INC. | $69.82 | 2019-2020 | |
| Amgen INC. | $45.98 | 2024-2025 | Krystexxa |
| Davol INC. | $41.11 | 2025 | Arista |
| Nevro Corp. | $36.67 | 2024 | Senza |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ets Wound Care LLC | $35.27 | 2025 | Mirragen Advanced Wound Matrix |
| Paragon 28, INC. | $33.08 | 2019-2024 | |
| Djo, LLC | $32.82 | 2024 | Cmf |
| Depuy Synthes Sales INC. | $30.16 | 2022 | |
| Hydrofera LLC | $26.98 | 2021 | |
| Lifenet Health | $24.38 | 2025 | Theragenesis Wound Matrix |
| Medtronic USA, INC. | $22.19 | 2019 | |
| Extremity Medical | $22.04 | 2019 | |
| Convatec INC. | $21.46 | 2023 | |
| Heron Therapeutics, INC. | $21.29 | 2021 | |
| Acell, INC. | $20.07 | 2019 | |
| Treace Medical Concepts, INC. | $18.12 | 2024 | |
| Hartmann USA, INC. | $16.49 | 2021 | |
| Assertio Therapeutics, INC. | $16.10 | 2020 | |
| Grt US Holding, INC. | $15.43 | 2022 | |
| In2bones USA, LLC | $15.31 | 2019 | |
| Arthrosurface Incorporated | $15.31 | 2019 | |
| Bioventus LLC | $14.88 | 2022 | |
| Integra Lifesciences Corporation | $12.47 | 2021 | |
| Osiris Therapeutics INC. | $12.26 | 2019 | |
| Orthofix Medical, INC. | $7.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Fitzgerald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.